Dicerna Pharmaceuticals

+$0.22 (+0.58%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can watch DRNA and buy or sell other stocks, options, and ETFs commission-free!

About DRNA

Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products.

CEO
Douglas M. Fambrough, III, PhD
Employees
—
Headquarters
Lexington, Massachusetts
Founded
2006

DRNA Key Statistics

Market cap
2.97B
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.20M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$40.14
52 Week low
$19.06

DRNA Earnings

-$0.53
-$0.22
$0.10
$0.41
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure